ElevateBio logo

ElevateBio

North America, Massachusetts, United States, Waltham

Description

ElevateBio is a biotechnology company that specializes in cell and gene-based therapies.

Investor Profile

ElevateBio has made 2 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Post Ipo Equity (50%)
  • Series A (50%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Clinical Trials
  • Pharmaceutical
  • Medical
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does ElevateBio frequently co-invest with?

EcoR1 Capital
North America, California, United States, San Francisco
Co-Investments: 1
Samsara BioCapital
North America, California, United States, Palo Alto
Co-Investments: 1
Gilead Sciences
North America, California, United States, Foster City
Co-Investments: 1
JDRF T1D Fund
North America, Massachusetts, United States, Boston
Co-Investments: 1
F2 Ventures
Europe, England, United Kingdom, London
Co-Investments: 1
GC
North America, Georgia, United States, Atlanta
Co-Investments: 1
Kite Pharma
North America, California, United States, Los Angeles
Co-Investments: 1
Redmile Group
North America, California, United States, San Francisco
Co-Investments: 1
Lightspeed Venture Partners
North America, California, United States, Menlo Park
Co-Investments: 1
Invus
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by ElevateBio?

AlloVir

Houston, Texas, United States

AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.

BiotechnologyClinical TrialsPharmaceutical
Post Ipo EquityJul 27, 2022
Amount Raised: $126,600,000
Abata Therapeutics

Cambridge, Massachusetts, United States

Abata Therapeutics is a biotech company.

BiotechnologyMedicalTherapeutics
Series AJun 23, 2021
Amount Raised: $95,000,000